Target- |
MechanismStem cell replacements |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study
The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects With Disability Following an Ischemic Stroke
A study of stereotactic, intracerebral injection of CTX0E03 neural stem cells into patients with moderate to moderately severe disability as a result of an ischemic stroke.
A Non-interventional Observational Clinical Study to Document the Clinical Course of Patients 12 Months or More Following an Ischaemic Stroke
A non-interventional observational clinical study to document the clinical course of patients at 12 months or more following an ischaemic stroke
100 Clinical Results associated with ReNeuron Ltd.
0 Patents (Medical) associated with ReNeuron Ltd.
100 Deals associated with ReNeuron Ltd.
100 Translational Medicine associated with ReNeuron Ltd.